Since PGI2 is known to negatively modulate RV remodeling in experimental PAH animals and PAH patients [45], [46], we hypothesized that HEXIM1, most likely via suppression of P-TEFb, takes part in cardiomyocyte regulation in RV. This evidence concerns the gene HEXIM1 and pulmonary arterial hypertension.